Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gene ENSG00000225965 encodes a pseudogene corresponding to Par-3 Partitioning Defective 3 Homolog (PARD3), which is a member of the cell polarity regulator protein family[3]. Unlike the functional PARD3 protein, which participates in cell polarity, asymmetrical cell division, and formation of tight junctions[1][4][5], this pseudogene does not encode a functional protein and is not relevant for therapeutic targeting, biomarker development, or drug interaction studies[3]. Summary context: - The functional PARD3 gene (not this pseudogene) encodes an adapter protein relevant to cell polarity and cancer research[1][5][12], but ENSG00000225965 is a non-coding pseudogene, not a protein-coding gene or druggable target[3]. - If seeking information on a valid therapeutic target, PARD3 (Partitioning defective 3 homolog) would be the canonical protein-coding gene, not this pseudogene entry[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Par-3 partitioning defective 3 homolog pseudogene (ENSG00000225965).